amodiaquine has been researched along with Malignant Melanoma in 1 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qiao, S | 1 |
| Tao, S | 1 |
| Rojo de la Vega, M | 1 |
| Park, SL | 1 |
| Vonderfecht, AA | 1 |
| Jacobs, SL | 1 |
| Zhang, DD | 1 |
| Wondrak, GT | 1 |
1 other study available for amodiaquine and Malignant Melanoma
| Article | Year |
|---|---|
The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death.
Topics: Amodiaquine; Antimalarials; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Cell Death; C | 2013 |